Boston Scientific (BSX) Revenue (2009 - 2026)

Boston Scientific has disclosed Revenue across 18 years of filings, most recently posting $5.2 billion for Q1 2026.

• Revenue for Q1 2026 came in at $5.2 billion, up 11.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.6 billion (up 17.44% YoY), and the FY2025 annual result was $20.1 billion, up 19.87% from the prior year.
• Revenue came in at $5.2 billion for Q1 2026 at Boston Scientific, down from $5.3 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $5.3 billion in Q4 2025 to a low of $3.0 billion in Q1 2022.
• The 5-year median for Revenue is $3.9 billion (2024), against an average of $4.1 billion.
• Across the five-year window, Revenue grew 3.68% in 2022 and grew 22.84% in 2025, its largest moves.
• Boston Scientific's Revenue stood at $3.2 billion in 2022, then climbed by 14.9% to $3.7 billion in 2023, then grew by 22.44% to $4.6 billion in 2024, then advanced by 15.9% to $5.3 billion in 2025, then declined by 1.57% to $5.2 billion in 2026.
• The last three Revenue figures came in at $5.2 billion (Q1 2026), $5.3 billion (Q4 2025), and $5.1 billion (Q3 2025), per Business Quant data.